Machine Science in Biomedicine: Practicalities, Pitfalls and Potential by Kelsey, T W & Wallace, W H B
Machine Science in Biomedicine: Practicalities, Pitfalls and Potential
T.W. Kelsey
School of Computer Science
University of St Andrews
St Andrews, United Kingdom
tom@cs.st-andrews.ac.uk
W.H.B. Wallace
Department of Reproductive and Developmental Sciences
Division of Child Life and Health, University of Edinburgh
Edinburgh, United Kingdom
hamish.wallace@nhs.net
Abstract—Machine Science, or Data-driven Research, is a
new and interesting scientific methodology that uses advanced
computational techniques to identify, retrieve, classify and
analyse data in order to generate hypotheses and develop
models. In this paper we describe three recent biomedical
Machine Science studies, and use these to assess the current
state of the art with specific emphasis on data mining, data
assessment, costs, limitations, skills and tool support.
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I. INTRODUCTION
Machine Science [1], or Data-driven Research [2], is
a new and interesting scientific methodology that uses
advanced computational techniques to find, classify and
analyse data in order to generate hypotheses and develop
models. It can be considered a re-ordering of the classical
approach to science, namely (i) generate a hypothesis, (ii)
design an experiment, (iii) collect data and (iv) analyse
and discuss. In the modern world there are huge resources
of organised scientific data, both in raw form and/or in
summarised form. For example, there is a long-standing
requirement for all published microarray studies that the
raw data is made available in a checkable repository [3],
proteomics research is moving towards a similar requirement
[4], and most scientific papers report summaries of their
data in charts and/or descriptive statistics. Moreover, the
explosion of knowledge in the form of digitised infor-
mation has led to huge advances in computational tools
and methods for searching, sorting and classifying data.
Taken together, this motivates an alternative approach to
science, namely (i) collect data, (ii) classify and organise
the data, (iii) choose an analytic methodology based on
the form, size and quality of the data, (iv) analyse and
model, (v) report new patterns, uncovered inconsistencies
and/or hypotheses that can be tested by future studies. This
approach is inherently multidisciplinary. The most important
Computer Science skills and techniques involve artificial
intelligence, data mining, machine learning, semantics &
ontologies, search, and modelling & abstraction. Mathemati-
cal skills include non-linear regression, differential equations
and statistical analysis. Without these, any Machine Science
study is unlikely to succeed. However, an extremely good
understanding of the literature in the target science is needed:
when combining datasets one has to be certain that they
were collected in similar ways, even though the laboratory
work may have been done on separate continents, in separate
decades and using separate equipment. Therefore a high
degree of professional understanding of the methods sections
of studies reported in the literature is needed.
Successful Machine Science studies have been published
in the fields of neurology [5], cancer research [6], physics
[7], biophysics [8] and ecology [9], [10]. Publications de-
scribing Machine Science tools and techniques for data
extraction and management include [11] and [12].
Machine Science is a hot topic in the theory and philos-
ophy of modern science, with recent claims that
“within a decade, even more powerful tools
will enable automated, high-volume hypothesis
generation to guide high-throughput experiments
in biomedicine, chemistry, physics, and even the
social sciences” [1].
But, with specific focus on biomedicine, what is the state
of the art now? Is it possible to collect high quality raw data
from existing studies? If not, can data be re-created from
published charts and descriptive statistics? To what extent
can the obvious problems involving natural languages, scien-
tific ontologies, entrenched scientific cultural viewpoints, ho-
mogeneity of data and standardisation of data from different
studies be overcome? Lastly – but possibly most importantly
– how much does it cost in time, effort and equipment to
produce high impact results in Machine Science. In this
paper we partially answer these questions. We describe three
recent biomedical Machine Science studies, and use these to
(i) assess the current state of the art, (ii) identify the tools
and techniques that currently support biomedical Machine
Science, and (iii) highlight those areas which are likely to
be resistant to successful full automation. The studies are all
in the same scientific area: human reproductive biomedicine.
They differ in the availability and the quality of the data, all
of which were obtained by careful aggregation of data from
studies published in the biomedical literature. The specific
results of the studies are unimportant: we focus on the
practicalities and limitations of the scientific methodology
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employed, together with descriptions of useful tool support.
The next three sections are detailed descriptions of the
Machine Science studies, together with the hypotheses gen-
erated in each case. In the final section we assess the
strengths and weaknesses of current biomedical Machine
Science, using both our exemplars and results from other
Machine Science studies.
II. ONE HOMOGENEOUS DATASET
We first describe a Machine Science study of human
ovarian reserve from conception to menopause. Several stud-
ies have taken human ovaries (either after surgical removal
or post-mortem); sliced, stained and mounted them; taken
photographic images of the histological slides; and counted
the number of non-growing follicles (NGFs) appearing in the
images. In mammals, the NGF population defines ovarian
reserve: once the population falls below about one thousand,
ovulation ceases. The studies typically involved subjects
with restricted age ranges – neo-natal, adolescent, fertile
age – and either reported the bare numbers (i.e. estimates
of NGF populations) or produced models describing rates
of decline of ovarian reserve that fitted their data and were
applicable only within the age ranges of the studies. No
model of ovarian reserve throughout life had been derived:
the separate studies often compared their results to other
studies, but reported only results based on their data.
The research question in biomedical Machine Science
was: can these studies be identified and collated in order
to produce a model of ovarian reserve that predicts (with
explicit limits on accuracy) both the growth in NGF popu-
lation after conception, and the subsequent decline in NGF
population until menopause? Derivation of such a model
would be useful for comparison of the age-related dynamics
of other indicators of human fertility, and could also lead to
new hypotheses being generated for future investigation by
reproductive biologists.
Our research methodology was to systematically search
the scientific literature for histological studies that estimated
human ovarian NGF populations, then extract the data
from these using automated or semi-automated techniques
wherever possible. After assessing the studies for homo-
geneity, we automatically fitted 268 mathematical models
to the combined dataset using TableCurve (Systat Software
Inc., San Jose, California, USA), and selected as the gold-
standard model the biologically plausible model with the
highest coefficient of determination (r2), Figure 1.
A. Data mining
We performed pubmed and medline searches, then fol-
lowed the references in returned articles to identify older
studies. Right from the start, the choice of search terms
presents problems. NGFs can, and are, also referred to as
primordial follicles in the literature. Moreover, the human
oocyte is not the same biological entity as an NGF, but there
is a one-one correspondence in their number so studies using
this terminology have to be included.
The strengths of the web-based search approach is that –
for recent publications – the data mining process is largely
automatic, with much of the non-intellectual work being
performed by computer. PDF versions of the more recent
studies – together with full cross-referenced bibliographic
information – can be automatically downloaded into a cloud-
based research tool for organising literature collections (we
use Mendeley, but there are several others available). From
the PDF it is possible to cut and paste tables into word-
processing software (e.g. Microsoft Word), convert these into
tables and export the result into a spreadsheet application
(e.g. Microsoft Excel).
Unfortunately, many of the studies were performed more
than 25 years ago (Table I). This data had to be extracted by
hand, since the journal articles had not yet been archived in
digital form. An extreme case was the 1951 PhD thesis by a
Swedish researcher, which was obtained only by application
in person at a medical library, followed by a wait of a few
weeks for the thesis to be copied and mailed. This problem
with older research remains, but many academic publishers
are in the process of releasing digitised historical archives,
so semi-automatic data mining should become easier in the
future.
It is not usual in biomedical literature to publish raw data
in tabular form. The most common method of displaying
data is in chart form with, for this study, age on the x-
axis and NGF population on the y-axis. The extraction of
individual datapoints is now semi-automated in the sense
that software (such as PlotDigitiser) can be used to calibrate
the axes, so that clicking on a datapoint entry loads an accu-
rate estimate of that datapoint into a spreadsheet. Accuracy
depends on the quality of the images of the charts, but in
our experience the inter- and intra-observer coefficients of
variation are very small (typically less than 2%). Repeated
datapoints are problematic: the study reports n subjects, but
there appears to be fewer points in the describing chart.
Often the missing points can be deduced by analysis of the
describing statistics for the data (e.g. median, minimum &
maximum; or mean ± one standard deviation).
Table I: The eight quantitative histological studies forming
the combined dataset
Study Statistics
First author Year Ovaries Min. age Max. age Median age
Bendsen 2006 11 -0.6 -0.6 -0.6
Baker 1963 11 -0.6 7.0 -0.2
Forabosco 2007 15 -0.5 0.5 -0.3
Block 1953 19 -0.2 0.0 0.0
Hansen 2008 122 0.1 51.0 38.0
Block 1951 86 6.0 44.0 28.0
Gougeon 1987 52 25.0 46.0 39.5
Richardson 1987 9 45.0 51.0 46.0
Overall 325 -0.6 51.0 32.0
Figure 1: Model of ovarian reserve from mined biomedical data
B. Data assessment
This stage involves the most multidisciplinary expertise:
can data from different studies be considered homogenous
in terms of (a) biomedical laboratory practice, (b) standard
levels of error, and (c) alignment with the Machine Science
study in question? The answer to these questions is for
the most part subjective, and will depend heavily on the
skills and experience of individual investigators. However,
it should be noted that – for many biomedical studies – the
errors in the data are higher than any errors induced by the
data mining process. There is no published standard error for
histological NGF population estimates, but it is likely to be
at least 10%. Data-mining errors are an order of magnitude
lower.
C. Results and hypotheses
Automated non-linear regression (or curve-fitting) is a
very powerful tool. Rather than selecting models in advance
and calculating goodness-of-fit, it is now possible to fit
hundreds of models to see which best fits the data. Our
model [13] shows for the first time that for 95% of women
by the age of 30 years only 12% of their ovarian reserve is
present and by the age of 40 years only 3% remains. Further
analysis of the model shows that the number of NGFs lost
per month peaks at age 14–15. This provides the hypotheses
that (a) changes in levels of NGF loss lead to puberty, (b)
hormonal pubertal factors lead to changes in NGF loss, (c)
the peak at this age is a fluke and there is no causal relation,
and (d) our model is simply wrong, with peak loss actually
occurring at some other age on average. Another hypothesis
generated by this study is that variations in NGF populations
are more related to age for younger women, with lifestyle
and genetic factors coming more into play later in life.
The key point is that these hypotheses are now testable
by biomedical researchers. There is a solid framework for
designing experiments in terms of event size, cohort size
needed, predicted outcomes, and confidence intervals. The
Machine Science study may well lead to a greater under-
standing of reproductive biomedicine by motivating studies
that would otherwise never be planned or undertaken.
D. Costs, limitations and caveats
This study was very cost efficient. The only non-human
expenditure involved was computer connected to the inter-
net, software costing a few hundred US dollars in license
fees, and small amounts of travel money for collaborative
research and editorial meetings. To perform one of the
studies that comprise our combined dataset, one would need
a fully equipped histology lab (with scanners, microscopes,
stains and ovens costing thousands of US dollars each), plus
the labour costs associated with obtaining ovaries, fixing,
slicing, staining and mounting them. In terms of academic
effort, again the Machine Science study was relatively inex-
pensive: much of the data acquisition was either automated
or semi-automated, as was much of the mathematical and
statistical analysis of the data. It takes many hours to count
NGFs appearing in histology images, with more than one
count needed to guard against individual mistakes.
The main limitation of the study is that the model is not
validated in any way. With only 325 datapoints covering
over 50 years of age, we are relying on future studies to
validate (or otherwise) the model or otherwise. Another
obvious limitation is that important data sources may have
been missed in the systematic search. This is particularly
true of research output published in languages other than
English; these papers are unlikely ever to be found by the
search procedure used, and would have to be interpreted by a
biomedical expert conversant with the publishing language.
Even though large parts of the research effort was per-
formed by computers, it simply isn’t possible to fully
automate this type of the study. Some of the data sources are
(in modern scientific terms) archaic, each paper has to be
read and interpreted by at least one expert human in order
to include or exclude its contents from the study.
III. TWO SIMILAR DATASETS: MACHINE LEARNING
In this section we describe a similar study to the ovarian
reserve model described in Section II. The key difference
is that we demonstrate that it is possible to overcome
the lack of model validation by using machine learning
techniques. The study involves the collection of data that
related serum Anti-Mu¨llerian Hormone (AMH) levels to
chronological age. AMH is known to be related to human
fertility, as it is produced by granulosa cells in the ovary.
It is known that AMH levels are below detection limits
for post-menopausal women, and are elevated in women
with polycystic ovarian system. As with ovarian reserve, no
model has been published that gives average AMH levels
for all ages, together with well-defined upper and lower
prediction limits.
A. Data mining
As before, a web-based search of the biomedical literature
was performed, taking great care to check for both for
different but synonymous labels, and also similarly-defined
but different data. AMH and MIS are synonyms, and nm/ml
and µm/l represent the same measure. However, there are
two different commercial assays used to measure AMH
levels in blood, and these will return different values when
used on the same sample. It is estimated that one gives values
roughly twice those of the other, but the true conversion
formula is probably hyperbolic and is simply not known.
We therefore separated the data by assay used. AMH
levels are easy, but expensive, to obtain in the laboratory, and
we found about two thousand datapoints. Again, wherever
possible, tabular data was imported directly into spread-
sheets, but in the general case data had to be extracted from
charts. In this case we also had access to raw data from an
as yet unpublished study.
B. Data assessment
This was, again, the most subjective and multidisciplinary
stage. Defining inclusion and exclusion criteria that ensured
that our study cohort could be assumed to approximate a nor-
mal fertile female population involved the identification of
control subjects from comparative studies and healthy sub-
jects from longitudinal studies. This process was painstaking
and manual, as was the careful analysis of standardisation
of studies in terms of assays, units, coefficients of variation
and detection limits.
C. Results and hypotheses
We collected two datasets of similar size and having
similar descriptive statistics (mean, median, max., min., and
SD). We fitted curves to one set – the training data – and
selected by highest coefficient of determination as before,
obtaining an r2 of 0.45 (Figure 2a). We then calculated the
residuals of the test data from this model, giving an r2 of
0.43 (Figure 2b). This 95% agreement in goodness-of-fit for
unseen data shows that the model can be used to accurately
describe independent serum AMH levels, and is therefore
highly likely to be correct in biomedical terms.
Comparison of the ovarian reserve and AMH models sug-
gests that ovarian activity (number of NGFs lost) correlates
either well or extremely well with levels of AMH in the
blood (birth to menopause correlation r = 0.81; birth to age
20 r = 0.95). However NGF population (or ovarian reserve)
correlates much less well (r = −0.88 and r = 0.38 for the
same age ranges). We can therefore hypothesise that AMH
and NGF loss are biologically related in some way as yet
unknown, especially early in life. As before, this hypothesis
can now be tested using the results of the Machine Science
study to design and assess the experiments.
D. Costs, limitations and caveats
This study cost a small fraction of the projected cost of a
laboratory-based study to answer the same research question.
We did not have to recruit 2,400 subjects, take blood samples
or measure hormone levels. Our main cost was in time taken
to ensure that the data collected was suitable as the basis for
a classical machine learning modelling approach. Moreover,
for this study most of the data came from recent (less than
ten years old) literature, making the data mining process
much simpler.
By using machine learning to validate the AMH model, it
is our opinion that the limitations and caveats associated with
the ovarian reserve study no longer apply. This model has
been independently validated and can hence be considered as
the gold-standard for this hormone in female human blood.
(a) Case I (b) Case II
Figure 2: Serum AMH model: traing data & test data
IV. DATA FROM DESCRIPTIVE STATISTICS
Ovarian volumes are another potential indirect indicator
of human reproductive capability [14]. Volumes are easily
obtainable using transvaginal ultrasound, with a standard
error of 10% or 12% for 2- and 3-dimensional ultrasound
respectively [15].
A. Data mining
Several studies have recorded volumes at known ages, but
the data is dominated by a single study involving 58,673
observations of 13,963 subjects aged 25–91 years [16]. Any
Machine Science study that did not include this data would
be seriously flawed, but the raw data is not available from
the research group that owns it. For obvious reasons they
did not produce a scatter plot containing 58,673 entries.
The published summary of the data consists of a chart with
entries for age, number of subjects of that age, mean volume
and the upper 95% prediction limit for that age. If volumes
were normally distributed, it would be simple to extract
the standard deviation from the prediction limit, then use a
statistical software package (such as R) to randomly create
a dataset containing the correct number of entries for each
age, with the distribution for each age satisfying the pre-
calculated normal variance. The resulting dataset would not
be identical to that obtained by the original study, but would
be statistically indistinguishable. Given the 12% standard
errors in the original data, we claim that the artificial dataset
is an accurate representation of ovarian volumes for that
many women of those ages. For lognormally distributed data
the situation is slightly harder. Given the published mean and
standard deviation, µ and σ, we can calculate their lognormal
equivalents, x and y, by solving the equations
µ = ex+
1
2y
2
σ = e2x+y
2
(ey
2 − 1).
We can then randomly create as many full datasets with
the same statistical properties as is needed to produce a
reliable model.
B. Data assessment
Is it sound scientific practice to recreate datasets from
partial information published in the biomedical literature?
We believe so, provided that the methodology used is
explicitly stated. The key strength, in terms of modelling,
is that many such datasets can be constructed, so that the
validity and robustness of any models produced can be
exhaustively analysed.
C. Results and hypotheses
Our results show both that ovarian reserve correlates
well with ovarian volume [14], although measurement errors
reduce the efficacy of this indirect test of ovarian reserve.
The hypothesis is that a combination of easily measured
indirect factors will produce a reliable test for the number of
years of reproductive life remaining for individual women.
D. Costs, limitations and tool support
The cost of taking 58,673 observations was immense. The
cost of using the results of this effort to produce comparative
models was very small. The tool support needed is a
textual data-mining system, a PDF to spreadsheet system, a
computer algebra system to solve the lognormal equations,
and a statistical analysis system to create datasets.
V. CONCLUSION
We have described three Machine Science studies, each
based on mined data from the biomedical literature. Our
primary conclusion is that biomedical Machine Science is
both cost-effective and effective, producing the first ever
models for important human biomedical attributes. High
quality tool support is easily available, and more is being
developed every year. The quantity and the quality of
retrievable data is also increasing with time. There are strong
bi-directional links with the more usual (often laboratory-
based) biomedical scientific approach: our Machine Science
is almost entirely based on published data obtained from
laboratory studies, and our hypotheses provide laboratory
research groups with new ideas for future experimental
directions.
Despite these benefits, pitfalls remain. Without a high
level of expertise in the subject area (specifically the ability
to understand and assess the minutiae contained in methods
sections of biomedical journal papers), successful Machine
Science is unlikely. It should also be remembered that
important data and information is contained only in paper
form, and until and unless all the scientific literature is both
digitised and searchable these important data can easily be
missed.
In summary, biomedical Machine Science is far from easy
and requires expert multidisciplinary collaboration, but it
leads to new insights, models and hypotheses that laboratory
based research is highly unlikely to uncover.
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